Biotechnology · Emeryville, CA · Founded 2018 · Privately Held (backing)
Developer of a novel DNA synthesis technology designed to simplify the biological research process. Ansa Biotechnologies is based in Emeryville, CA and was founded in 2018. It was valued at $269 million at its later-stage round in Oct 2025, the last priced event on record. It has raised $140 million across 4 recorded rounds; the latest was a $46.4 million early-stage round in Jun 2024.
PMV mark · valuation
$269.0M
Oct 2026
Priced at
its later-stage round
Oct 2025
Total raised
$139.6M
Last round
Early Stage VC
Jun 2024
Cap table — not yet on record
Ansa Biotechnologies's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ansa Biotechnologies with a free account
·The complete investor list: 27 names
·Watch Ansa Biotechnologies: the Monday email on marks, rounds and moves
Where does Ansa Biotechnologies's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Ansa Biotechnologies's 4 recorded funding rounds.
